Is surgical treatment necessary in all hydronephrotic kidney allografts?
Abstract
Background/Aim. The management of kidney graft hydronephrosis (KGH) is usually surgical, although some cases require expectant management and follow-up. The aim of the study was to discuss the criteria for expectant management or immediate surgical intervention in the series of patients with KGH. Methods. The paper is based on a retrospective study of 42 patients with KGH. The patients underwent kidney transplantation from January 2007 to December 2012. There were 19 cadaveric donor recipients and 23 living donor recipients. The average follow-up was 15,2 (range 12–21) months. The average recipient`s age was 41,6 years. In every case study, the diagnosis of graft hydronephrosis was established using abdominal ultrasonography. The degree of hydronephrosis was estimated on the basis of measuring the maximal diameter of the pelvicalyceal dilatation (PD). Results. There were no patients with graft failure after the period during which they were under medical observation. Hydronephrosis resolved completely in six (14%) patients. The median maximal PD was 28 ± 9 (range 14 –38) mm and the median last PD was 23 ± 11 (range 0–35) mm and they did not differ significantly (p = 0.23). The last serum creatinine was significantly lower than the maximal creatinine value (p < 0.05). In twelve (29%) patients renal function normalized. Renal function remained stable during the period of medical observation. At the end of the follow-up, all patients had sterile urine culture. Conclusion. The traditional doctrine, according to which KGH represents an absolute indication for surgery, can be debated; the majority of the patients observed require just active surveillance. Prompt surgical correction is recommended only in cases with increasing pelvicalyceal dilatation and the development of symptoms, progressively decreasing renal function or recurrent urinary tract infection.
References
Yigit B, Tellioglu G, Berber I, Aydin C, Kara M, Yanaral F, et al. Surgical treatment of urologic complications after renal trans-plantation. Transplant Proc 2008; 40(1): 202−4.
Nadri QJ, Nabi Z. Nonobstructive hydronephrosis of a kidney transplant. Saudi J Kidn Dis Transplant 2010; 21(6): 1140−2.
Burgos FJ, Pascual J, Marcen R, García-Navas R, García IG, Alarcón C, et al. Self-expanding metallic ureteral stents for treatment of ureteral stenosis after kidney transplantation. Transplant Proc 2005; 37(9): 3828−9.
Minnee RC, Surachno S, Kox C, Ten BI, Aronson DC, Idu MM. Is a selective splinted ureterocystostomy protocol feasible in renal transplantation? An analysis of 475 renal transplantations. Transpl Int 2006; 19(7): 558−62.
Emiroğlu R, Karakayall H, Sevmiş S, Akkoç H, Bilgin N, Haberal M. Urologic complications in 1275 consecutive renal trans-plantations. Transplant Proc 2001; 33(1−2): 2016−7.
Chmura A, Rowinski W, Walaszewski J, Czaplicki M, Kwiatkowski A, Trzebicki J. Treatment of early and late urinary complications after kidney transplantation. Transplant Int 2007; 20(Suppl 2): 189.
Van Gansbeke D, Segebarth C, Toussaint C, Matos C, Gevenois PA, Kinnaert P, et al. Non-obstructive kidney transplant dysfunction: Magnetic resonance evaluation. Br J Radiol 1988; 61(726): 473−9.
Oosterhof GO, Hoitsma AJ, Witjes JA, Debruyne FM. Diagnosis and treatment of urological complications in kidney transplan-tation. Urol Int 1992; 49(2): 99−103.
Katz R, Pode D, Gofrit ON, Shenfeld OZ, Landau EH, Golijanin D, et al. Transurethral incision of ureteroneocystostomy strictures in kidney transplant recipients. BJU Int 2003; 92(7): 769−71.
Gurkan A, Yakupoglu YK, Dinckan A, Erdogdu T, Tuncer M, Erdoğan O, et al. Comparing two ureter reimplantation tech-nique in kidney transplant recipients. Transpl Int 2006; 19(10): 802−6.
Faenza A, Nardo B, Catena F, Scolari MP, d'Arcangelo GL, Busca-roli A, et al. Ureteral stenosis after kidney transplantation: A study on 869 consecutive transplants. Transpl Int 1999; 12(5): 334−40.
Zietek Z, Sulikowski T, Tejchman K, Sieńko J, Janeczek M, Iwan-Zietek I, et al. Lymphocele after kidney transplantation. Trans-plant Proc 2007; 39(9): 2744−7.
Strang AM, Lockhart ME, Amling CL, Kolettis PN, Burns JR. Living renal donor allograft lithiasis: A review of stone related morbidity in donors and recipients. J Urol 2008; 179(3): 832−6.
Keller LS, Peh CA, Nolan J, Bannister KM, Clarkson AR, Faull RJ. Transplant nephropathy successfully treated with cidofovir. Nephrol Dial Transplant 2003; 18(5): 1013−4.
Leikis MJ, Denford AJ, Pidgeon GB, Hatfield PJ. Post renal transplant obstruction caused by cytomegalovirus ureteritis. Nephrol Dial Transplant 2000; 15(12): 2063−4.
Brown ED, Chen MY, Wolfman NT, Ott DJ, Watson NE. Com-plications of Renal Transplantation: Evaluation with US and Radionuclide Imaging. Radio Graphics 2000; 20(3): 607−22.
Jaskowski A, Jones RM, Murie JA, Morris PJ. Urological compli-cations in 600 consecutive renal transplants. BMJ 1987; 74(10): 922−5.
Taylor RJ, Landreneau MD, Makowka L, Rosenthal TJ, Gordon RD, Tzakis AG, et al. Cyclosporine immunosuppression and delayed graft function in 455 cadaveric renal transplants. Transplant Proc 1987; 19(1 Pt 3): 2100−3.
Kamath NS, John GT, Neelakantan N, Kirubakaran MG, Jacob CK. Acute graft pyelonephritis following renal transplantation. Transpl Infect Dis 2006; 8(3): 140−7.
Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62(1): 311−8.
Larson DM, Malone JM, Copeland LJ, Gershenson DM, Kline RC, Stringer CA. Ureteral assessment after radical hysterectomy. Obstet Gynecol 1987; 69(4): 612−6.